目的探究2型糖尿病并发骨质疏松患者血清白脂素(Asprosin)、巨噬细胞炎症蛋白-1β(macrophageinflammato-ry protein-1β,MIP-1β)水平与骨密度及骨代谢指标的相关性。方法选取2022年4月~2023年4月在承德市中心医院就诊的172例2型糖尿...目的探究2型糖尿病并发骨质疏松患者血清白脂素(Asprosin)、巨噬细胞炎症蛋白-1β(macrophageinflammato-ry protein-1β,MIP-1β)水平与骨密度及骨代谢指标的相关性。方法选取2022年4月~2023年4月在承德市中心医院就诊的172例2型糖尿病患者为研究对象,并根据骨密度值结果分为2型糖尿病组(n=103)和2型糖尿病并发骨质疏松组(n=69);采用ELISA法测定血清Asprosin,MIP-1β水平;Pearson法分析血清Asprosin,MIP-1β表达水平与骨密度的相关性;Logistic回归分析2型糖尿病并发骨质疏松的影响因素;受试者工作特征(ROC)曲线分析血清Asprosin,MIP-1β水平对2型糖尿病并发骨质疏松的预测价值。结果与2型糖尿病组比,2型糖尿病并发骨质疏松组患者血清β-CTX(0.48±0.08ng/ml vs 0.42±0.04ng/ml),Asprosin(2.26±0.56ng/ml vs 1.65±0.36ng/ml),MIP-1β(26.01±6.43pg/ml vs 19.46±4.27pg/ml)水平均显著升高,骨密度(0.67±0.13g/cm2 vs 0.84±0.17g/cm2),BGP(8.33±1.23ng/ml vs 9.54±1.42ng/ml),T-P1NP(30.38±3.27ng/ml vs 32.49±3.29ng/ml)水平降低,差异具有统计学意义(t=6.501,8.699,8.032,7.039,5.773,4.133,均P<0.05);Pearson法分析显示,2型糖尿病并发骨质疏松组患者血清Asprosin,MIP-1β水平均与骨密度呈负相关(r=-0.484,-0.498,均P<0.05);Logistic回归分析显示血清Asprosin,MIP-1β水平均为影响2型糖尿病并发骨质疏松发生的独立危险因素(均P<0.05);ROC曲线分析显示,血清Asprosin,MIP-1β水平预测2型糖尿病患者并发骨质疏松的AUC分别为0.768,0.704,联合预测的AUC为0.859,优于二者单独预测(Z=1.812,2.895,均P<0.05)。。结论2型糖尿病患者并发骨质疏松患者血清Asprosin,MIP-1β水平显著升高,二者水平与骨密度密切相关,血清Asprosin,MIP-1β是2型糖尿病发生骨质疏松的独立危险因素,二者联合检测对疾病发展有较高的预测价值。展开更多
Asprosin is a newly discovered protein hormone that promotes appetite,regulates glucose homeostasis,increases insulin resistance and has potential myocardial protection.Myocardium is vulnerable to oxidative stress inj...Asprosin is a newly discovered protein hormone that promotes appetite,regulates glucose homeostasis,increases insulin resistance and has potential myocardial protection.Myocardium is vulnerable to oxidative stress injury caused by factors such as high glucose,anti-tumor drugs,ischemia reperfusion and so on,and currently there is a lack of effective preventive measures.It has been reported in the literature that Asprosin has a unique protective effect on myocardium,but the protective mechanism of Asprosin is not clear.In this paper,the general situation and functions of Asprosin,as well as the protective mechanism of Asprosin on myocardium were reviewed,in order to provide reference for the application of Asprosin in the treatment of cardio-related diseases.展开更多
文摘目的探究2型糖尿病并发骨质疏松患者血清白脂素(Asprosin)、巨噬细胞炎症蛋白-1β(macrophageinflammato-ry protein-1β,MIP-1β)水平与骨密度及骨代谢指标的相关性。方法选取2022年4月~2023年4月在承德市中心医院就诊的172例2型糖尿病患者为研究对象,并根据骨密度值结果分为2型糖尿病组(n=103)和2型糖尿病并发骨质疏松组(n=69);采用ELISA法测定血清Asprosin,MIP-1β水平;Pearson法分析血清Asprosin,MIP-1β表达水平与骨密度的相关性;Logistic回归分析2型糖尿病并发骨质疏松的影响因素;受试者工作特征(ROC)曲线分析血清Asprosin,MIP-1β水平对2型糖尿病并发骨质疏松的预测价值。结果与2型糖尿病组比,2型糖尿病并发骨质疏松组患者血清β-CTX(0.48±0.08ng/ml vs 0.42±0.04ng/ml),Asprosin(2.26±0.56ng/ml vs 1.65±0.36ng/ml),MIP-1β(26.01±6.43pg/ml vs 19.46±4.27pg/ml)水平均显著升高,骨密度(0.67±0.13g/cm2 vs 0.84±0.17g/cm2),BGP(8.33±1.23ng/ml vs 9.54±1.42ng/ml),T-P1NP(30.38±3.27ng/ml vs 32.49±3.29ng/ml)水平降低,差异具有统计学意义(t=6.501,8.699,8.032,7.039,5.773,4.133,均P<0.05);Pearson法分析显示,2型糖尿病并发骨质疏松组患者血清Asprosin,MIP-1β水平均与骨密度呈负相关(r=-0.484,-0.498,均P<0.05);Logistic回归分析显示血清Asprosin,MIP-1β水平均为影响2型糖尿病并发骨质疏松发生的独立危险因素(均P<0.05);ROC曲线分析显示,血清Asprosin,MIP-1β水平预测2型糖尿病患者并发骨质疏松的AUC分别为0.768,0.704,联合预测的AUC为0.859,优于二者单独预测(Z=1.812,2.895,均P<0.05)。。结论2型糖尿病患者并发骨质疏松患者血清Asprosin,MIP-1β水平显著升高,二者水平与骨密度密切相关,血清Asprosin,MIP-1β是2型糖尿病发生骨质疏松的独立危险因素,二者联合检测对疾病发展有较高的预测价值。
基金Scientific Research Foundation of Sichuan Science and Technology Department(Sichuan Science and Technology[2012]No.62012JY0068)。
文摘Asprosin is a newly discovered protein hormone that promotes appetite,regulates glucose homeostasis,increases insulin resistance and has potential myocardial protection.Myocardium is vulnerable to oxidative stress injury caused by factors such as high glucose,anti-tumor drugs,ischemia reperfusion and so on,and currently there is a lack of effective preventive measures.It has been reported in the literature that Asprosin has a unique protective effect on myocardium,but the protective mechanism of Asprosin is not clear.In this paper,the general situation and functions of Asprosin,as well as the protective mechanism of Asprosin on myocardium were reviewed,in order to provide reference for the application of Asprosin in the treatment of cardio-related diseases.
文摘目的:研究2型糖尿病患者血清Asprosin水平变化及其与代谢指标的相关性。方法:收集初诊2型糖尿病患者(type 2diabetes mellitus,T2DM)98例和正常糖耐量人群(normal glucose tolerance,NGT)93例。进一步根据中国超重/肥胖医学营养治疗专家共识(2016年版),以体质量指数(body mass index,BMI)≥28 kg/m2为切点,将上述2组组内分别再分为非肥胖(non-obesity,NOB)和肥胖(obesity,OB)两亚组。测量人体指标、检测相关代谢血生化指标,采用ELISA检测血清Asprosin水平,并通过直线相关性分析、多元线性回归分析对Asprosin水平及其与其他代谢指标的相关性进行统计分析。结果:T2DM组Asprosin水平明显高于NGT组[(352.579±40.742)pg/mL vs.(189.411±32.635)pg/mL,P=0.002]。单因素相关分析显示,T2DM患者血清Asprosin水平与高密度脂蛋白胆固醇(high density lipoprotein-cholesterol,HDL-C)呈负相关(r=-0.447,P=0.000),与空腹血糖(fasting blood glucose,FBG)、空腹胰岛素(fasting insulin,FINS)、胰岛素抵抗指数(homeostasis model of assessment for insulin resistance index,HOMA-IR)、糖化血红蛋白(glycosylated hemoglobin,HbA1c)呈正相关(r=0.187,r=0.198,r=0.202,r=0.159,均P<0.05)。多元逐步回归分析发现,FBG(β=0.333,P=0.000)、HOMA-IR(β=-0.176,P=0.047)为血清Asprosin的独立影响因素。结论:T2DM组血清Asprosin水平明显高于NGT组,且与FBG、FINS、HOMA-IR、HbA1c呈正相关,与HDL-C呈负相关,其中FBG与HOMA-IR是血清Asprosin水平的独立危险因素。
